H.R. 6283 118th Congress House

DRUG Act

Official title: To improve services provided by pharmacy benefit managers.

Introduced: December 6, 2023 Introduced by: Mariannette Miller-Meeks Republican · Iowa See on congress.gov

Health Civil actions and liabilityHealth care costs and insurancePrescription drugsUser charges and fees

Everywhere this bill has been 6 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 17, 2024

Referred to the Subcommittee on Health.

Feb 6, 2024

Ordered to be Reported (Amended) by the Yeas and Nays: 29 - 11.

Feb 6, 2024

Committee Consideration and Mark-up Session Held

Nov 10, 2023

Referred to the Subcommittee on Health.

Nov 8, 2023

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and the Workforce, and Oversight and Accountability, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Nov 8, 2023

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action December 17, 2024

Referred to the Subcommittee on Health.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 6

Education and Workforce Committee
House of Representatives
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Ways and Means Committee
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Oversight and Government Reform Committee
House of Representatives
Ways and Means Committee
House of Representatives

Lobbying activity 21

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

AEGIS LLC
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 3rd Quarter 2026 (July 1 - Sep 30)
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 2nd Quarter 2026 (Apr 1 - June 30)
AEGIS LLC
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 1st Quarter 2026 (Jan 1 - Mar 31)
AEGIS LLC
for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

HOUSE OF REPRESENTATIVES
21 filings
SENATE
21 filings
Health & Human Services, Dept of (HHS)
10 filings
Commerce, Dept of (DOC)
5 filings
U.S. Trade Representative (USTR)
5 filings
Centers For Medicare and Medicaid Services (CMS)
4 filings
Office of Management & Budget (OMB)
4 filings
Patent & Trademark Office (PTO)
3 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 21 filings →

Cosponsors 25